AI at Scale for Clinical Impact (ASCI): Cancer Pathology Foundation Models

The meeting examines scalable cancer AI built from pathology together with molecular assays, imaging, genomic information and longitudinal clinical records. Researchers and clinicians discuss multimodal methods and the evidence needed to move from slide-level predictions toward reliable diagnosis, prognosis and treatment research. Session: 08:00–17:00 (Australia/Sydney). A paid NeurIPS virtual pass includes workshop livestreams; on-site access follows the host-location registration rules.